GlycoMimetics Inc (GLYC)
1.925
-0.23
(-10.67%)
USD |
NASDAQ |
Apr 19, 16:00
1.925
0.00 (0.00%)
After-Hours: 19:38
GlycoMimetics Shareholders Equity (Quarterly): 38.41M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.41M |
| September 30, 2023 | 46.55M |
| June 30, 2023 | 54.80M |
| March 31, 2023 | 62.18M |
| December 31, 2022 | 42.93M |
| September 30, 2022 | 48.12M |
| June 30, 2022 | 55.73M |
| March 31, 2022 | 68.03M |
| December 31, 2021 | 81.60M |
| September 30, 2021 | 96.57M |
| June 30, 2021 | 112.29M |
| March 31, 2021 | 125.12M |
| December 31, 2020 | 128.22M |
| September 30, 2020 | 138.27M |
| June 30, 2020 | 145.75M |
| March 31, 2020 | 148.49M |
| December 31, 2019 | 154.20M |
| September 30, 2019 | 167.08M |
| June 30, 2019 | 178.56M |
| March 31, 2019 | 192.79M |
| December 31, 2018 | 205.46M |
| September 30, 2018 | 218.10M |
| Date | Value |
|---|---|
| June 30, 2018 | 227.99M |
| March 31, 2018 | 238.04M |
| December 31, 2017 | 119.70M |
| September 30, 2017 | 108.56M |
| June 30, 2017 | 115.43M |
| March 31, 2017 | 31.89M |
| December 31, 2016 | 35.30M |
| September 30, 2016 | 41.75M |
| June 30, 2016 | 48.88M |
| March 31, 2016 | 34.77M |
| December 31, 2015 | 40.47M |
| September 30, 2015 | 48.70M |
| June 30, 2015 | 55.22M |
| March 31, 2015 | 44.36M |
| December 31, 2014 | 50.80M |
| September 30, 2014 | 57.71M |
| June 30, 2014 | 63.88M |
| March 31, 2014 | 55.35M |
| December 31, 2013 | 2.907M |
| September 30, 2013 | 6.515M |
| June 30, 2013 | 9.738M |
| December 31, 2012 | 12.53M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
38.41M
Minimum
Dec 2023
178.56M
Maximum
Jun 2019
99.63M
Average
96.57M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Altimmune Inc | 194.10M |
| Cellectar Biosciences Inc | -1.356M |
| PDS Biotechnology Corp | 26.13M |
| Syros Pharmaceuticals Inc | 16.66M |
| Precision BioSciences Inc | 18.86M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.32M |
| Total Liabilities (Quarterly) | 6.902M |
| Current Ratio | 6.407 |